Antiplatelet therapy is beneficial for secondary prevention in symptomatic carotid stenosis and perioperatively during revascularization, but lacks strong evidence for asymptomatic patients.
No takes yet. Share an insight, caveat, or question.
Reinforces antiplatelet use for symptomatic carotid stenosis and revascularization; leaves open benefit in asymptomatic patients.
Paciaroni et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: